- Joined
- Aug 2, 2013
- Messages
- 1,122
European Agency Recommends Approval of Stelara to Treat Crohn’s Disease
http://ibdnewstoday.com/2016/09/23/european-agency-recommends-approval-stelara-crohns-disease/
“The Committee for Medicinal Products for Human Use (CHMP), the scientific board of European Medicines Agency (EMA), has issued a positive opinion on Janssen’s Stelara (ustekinumab) for the treatment of patients with moderate-to-severe active Crohn’s disease, and for whom other therapies have failed.
The European Commission (EC) now will review CHMP’s opinion, with a final decision concerning marketing authorization for Stelara expected later this year. If the EC grants approval, Stelara will be marketed in the European Union and will be the first interleukin-12/23 inhibitor approved for Crohn’s disease.
…………………
Janssen also has submitted applications, currently under review, with the U.S. Food and Drug Administration seeking approval of Stelara for the treatment of moderate-to-severe Crohn’s disease.”
http://ibdnewstoday.com/2016/09/23/european-agency-recommends-approval-stelara-crohns-disease/
“The Committee for Medicinal Products for Human Use (CHMP), the scientific board of European Medicines Agency (EMA), has issued a positive opinion on Janssen’s Stelara (ustekinumab) for the treatment of patients with moderate-to-severe active Crohn’s disease, and for whom other therapies have failed.
The European Commission (EC) now will review CHMP’s opinion, with a final decision concerning marketing authorization for Stelara expected later this year. If the EC grants approval, Stelara will be marketed in the European Union and will be the first interleukin-12/23 inhibitor approved for Crohn’s disease.
…………………
Janssen also has submitted applications, currently under review, with the U.S. Food and Drug Administration seeking approval of Stelara for the treatment of moderate-to-severe Crohn’s disease.”